Updated Jul 16, 2026
Lambert Nicole has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Nicole Lambert (as listed as Lambert Nicole in the SEC filings) is identified as a director of Arcus Biosciences, Inc. in the most recent SEC filing dated 2026-06-12. The available context confirms her governance role on Arcus Biosciences' board, but does not provide additional biographical details or prior career background. There is no indication within the provided SEC context of her death; if there is any doubt about living status, authoritative sources should be consulted to confirm.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | RCUS | Arcus Biosciences, Inc. | A — Grant or award | 5.7K | $0.00 |
Nicole Lambert (as listed as Lambert Nicole in the SEC filings) is identified as a director of Arcus Biosciences, Inc. in the most recent SEC filing dated 2026-06-12. The available context confirms her governance role on Arcus Biosciences' board, but does not provide additional biographical details or prior career background. There is no indication within the provided SEC conte…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lambert Nicole profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.